期刊文献+

ACEI和ARBs在糖尿病并发高血压中的应用 被引量:1

Effects of ACEI and ARBs on Diabetes Mellitus
下载PDF
导出
摘要 肾素血管紧张素醛固酮系统(RAAS)参与糖尿病及其血管并发症的整个过程,此外糖尿病、高血压、动脉粥样硬化又激活RAAS,形成一个血管紧张素Ⅱ(AngⅡ)的恶性循环。血管紧张素转化酶抑制剂(ACEI)和血管紧张素Ⅱ受体阻断剂(ARBs)两类药物可以阻断RAAS,在治疗糖尿病合并高血压、肾病、冠脉疾病、心力衰竭等方面有着重要的作用。 Rennin - angiotensin - aldosterone system (RAAS) play an important role in the progress of diabetes mellitus and vaso- complication. Moreover, diabetes mellitus, hypertension, artherosclerosis can activate RAAS, which forms an infernal circle of angiotension Ⅱ (Ang Ⅱ ). Angiotensin - converting enzyme inhibitor and angiotensin Ⅱ receptor blockers can block RAAS so that they have an effect on diabetes mellitus incorporating hypertension, nephropathy, coronary artery disease, heart failure and etc.
出处 《中西医结合心脑血管病杂志》 2006年第7期615-617,共3页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
关键词 血管紧张素转化酶抑制剂 血管紧张素Ⅱ受体阻断剂 糖尿病 ACEI angiotensin Ⅱ receptor blockers diabetes mellitus
  • 相关文献

参考文献9

  • 1Forbes JM, Thorpe SR,Thallas- Bonke V. Modulation of soluble receptor for advanced glycation end products by Angiotensin - converting enzyme - 1 inhibition in diabetic nephropathy [J]. J Am Soc Nephrol, 2005,16 (8) : 2363 - 2372.
  • 2Giacomo deferrari, Maura Ravera, Valeria Berruti. Optimizing therapy in the diabetic patient with renal disease: Antihypertensive treatment[J] .J Am Soc Nephrol,2004,15:S6 -S11.
  • 3Microalbuminuria Captopril Study Group. Captopril reduce the risk of nephropathy in IDDM patients with microalbuminuria [J]. Diabetologis, 1996,39 : 587 - 593.
  • 4Temporary angiotensin Ⅱ blockade at the prediabetic stage attenuates the development of renal injury in type 2 Diabetic Rats[J]. J Am Soc Nephrol, 2005,16 : 703 - 711.
  • 5Dick de Zeeuw, Giuseppe Remuzzi, Hans- Henrik Parring, Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy, Lessons from RENAAL[J]. Kidney Intemational,2004,65(6) : 1 - 5.
  • 6Parving HH,Brenner BM,Cooper ME. Effect of losartan on renal and cardiovascular complications of patients with type 2 diabetes and nephropathy[J]. Ugeskr Laeger,2001,163(40) : 5514 - 5519.
  • 7Parring HH, Andersen S,Jacobsen P. Angiotensin receptor blockers in diabetic nephropathy: Renal and cardiovascular end points [J]. Semin Nephrol,2004,24(2) : 147 - 157.
  • 8Scheen AJ. Prevention of type 2 diabetes mellitus through inhibition of the renin - angiotensin system [J]. Drugs, 2004, 64 ( 22 ) : 2537 -2565.
  • 9Forbes JM, Thorpe SR, Thallas- Bonke V. Modulation of soluble receptor or advanced glycation end products by Angiotensin - converting enzyme- 1 inhibition in diabetic nephropathy[J]. J Am Soc Nephrol,2005,16 (8) : 2363 - 2372.

同被引文献3

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部